MC1649A1 - Phosphatides d'ethers de la glycerine - Google Patents

Phosphatides d'ethers de la glycerine

Info

Publication number
MC1649A1
MC1649A1 MC851758A MC1758A MC1649A1 MC 1649 A1 MC1649 A1 MC 1649A1 MC 851758 A MC851758 A MC 851758A MC 1758 A MC1758 A MC 1758A MC 1649 A1 MC1649 A1 MC 1649A1
Authority
MC
Monaco
Prior art keywords
radicals
oxy
alkyl
multiplet
compounds
Prior art date
Application number
MC851758A
Other languages
English (en)
French (fr)
Inventor
Manfred Breuninger
Dieter Schmidt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1649A1 publication Critical patent/MC1649A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/164—Unsaturated ethers containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
MC851758A 1984-03-15 1985-03-13 Phosphatides d'ethers de la glycerine MC1649A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH128784 1984-03-15
CH49185 1985-02-04

Publications (1)

Publication Number Publication Date
MC1649A1 true MC1649A1 (fr) 1986-04-07

Family

ID=25684726

Family Applications (1)

Application Number Title Priority Date Filing Date
MC851758A MC1649A1 (fr) 1984-03-15 1985-03-13 Phosphatides d'ethers de la glycerine

Country Status (16)

Country Link
US (1) US4694084A (da)
EP (1) EP0154977B1 (da)
AR (1) AR241022A1 (da)
AU (1) AU574440B2 (da)
CA (1) CA1264162A (da)
DE (1) DE3570239D1 (da)
DK (1) DK117985A (da)
ES (2) ES8606233A1 (da)
FI (1) FI78299C (da)
HU (1) HU195828B (da)
IL (1) IL74540A (da)
MC (1) MC1649A1 (da)
NO (1) NO851006L (da)
NZ (1) NZ211368A (da)
PH (1) PH20750A (da)
PT (1) PT80112B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
EP0284395B1 (en) * 1987-03-24 1993-06-23 Nippon Chemiphar Co., Ltd. Novel glycerol derivative and anti-hypertensive agent
CA2033725C (en) * 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
FR2687314A1 (fr) * 1992-02-18 1993-08-20 Oreal Dispersion de vesicules lipidiques, composition cosmetique et/ou pharmaceutique la contenant et procede de preparation de ladite dispersion.
AU2245295A (en) * 1994-04-15 1995-11-10 Hemagen/Pfc Fluorochemical emulsions containing 1,3-dialkylglycerophosphoryl choline surfactants and methods of use
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
ATE345780T1 (de) * 2001-07-13 2006-12-15 Nanocarrier Co Ltd Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
AU2002951216A0 (en) * 2002-09-05 2002-09-19 Dbl Australia Pty Ltd Surfactants and lyotropic phases formed therefrom
CA2546482A1 (en) * 2003-09-01 2005-03-10 F H Faulding & Co Limited Compositions and methods for delivery of biologically active agents
DE102005016152A1 (de) * 2005-04-07 2006-10-12 Basf Ag Herstellung von (Co)Tensiden durch Umsetzung von Polyolen mit Olefinen
EP2788006B1 (en) 2011-12-07 2026-01-07 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
US12071516B2 (en) 2014-09-04 2024-08-27 Nano Precision Medical, Inc. Polymeric stabilizing formulations
US10479868B2 (en) 2014-09-04 2019-11-19 Nano Precision Medical, Inc. Polymeric stabilizing formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
DE2820893C2 (de) * 1978-05-12 1986-02-20 A. Nattermann & Cie GmbH, 5000 Köln Strukturanaloga von natürlichen Phospholipiden und Verfahren zur Herstellung dieser Verbindungen
CA1173360A (en) * 1979-06-22 1984-08-28 Jurg Schrank Pharmaceutical preparations
DE3011738A1 (de) * 1980-03-26 1981-10-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerin-3-phosphorsaeurehalogenalkylester
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4493832A (en) * 1981-07-03 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Certain glycerol-phosphoryl choline derivatives, compositions containing same and method of using same
US4562179A (en) * 1982-04-19 1985-12-31 Fujisawa Pharmaceutical Co., Ltd. Phospholipid derivatives, and pharmaceutical composition of the same
JPS59163389A (ja) * 1983-03-07 1984-09-14 Takeda Chem Ind Ltd リン脂質
JPS59184195A (ja) * 1983-04-04 1984-10-19 Takeda Chem Ind Ltd グリセロ−ル誘導体

Also Published As

Publication number Publication date
AU574440B2 (en) 1988-07-07
US4694084A (en) 1987-09-15
PH20750A (en) 1987-04-02
DE3570239D1 (en) 1989-06-22
FI850972A0 (fi) 1985-03-12
EP0154977A2 (de) 1985-09-18
HU195828B (en) 1988-07-28
ES8606233A1 (es) 1986-04-16
DK117985A (da) 1985-09-16
ES541242A0 (es) 1986-04-16
IL74540A0 (en) 1985-06-30
FI850972L (fi) 1985-09-16
PT80112B (en) 1987-03-24
AR241022A1 (es) 1991-04-30
CA1264162A (en) 1990-01-02
NZ211368A (en) 1988-11-29
AU3971085A (en) 1985-09-19
FI78299C (fi) 1989-07-10
EP0154977B1 (de) 1989-05-17
DK117985D0 (da) 1985-03-14
IL74540A (en) 1989-02-28
NO851006L (no) 1985-09-16
FI78299B (fi) 1989-03-31
PT80112A (en) 1985-04-01
AR241022A2 (es) 1991-04-30
EP0154977A3 (en) 1986-02-19
ES8703481A1 (es) 1987-02-16
HUT36824A (en) 1985-10-28
ES550920A0 (es) 1987-02-16

Similar Documents

Publication Publication Date Title
MC1649A1 (fr) Phosphatides d'ethers de la glycerine
FR2596393A1 (fr) Derives de l'acide hydroxy-3 dihydroxyoxophosphorio-4 butanoique, leur procede de preparation, leur application comme medicament et les compositions les renfermant
EP0121088B1 (en) New o-acyl-alkanediol-phospholipids, processes for their preparation and pharmaceutical preparations containing them
MC1639A1 (fr) Derives de la glycerine
JPH0368038B2 (da)
EP0209770A1 (fr) Esters et amides de l'acide eicosatriynoique et leur application en pharmacie et en cosmétique
EP0318392B1 (fr) Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0006789A1 (fr) Composés bis (aryloxyalcanecarboxyliques), leur préparation et leur utilisation en thérapeutique
FR2593505A1 (fr) Ester phosphorique substitue par la serine et son procede de fabrication
US20030171621A1 (en) Process for the synthesis of sphingosine
FR2567514A1 (fr) Nouveaux ether-oxydes derives de cyclopropylphenols
EP0074873A1 (fr) Dérivés de phénoxy-3 propanol-2, leur préparation et leur application en thérapeutique
EP0491263A1 (de) Phenylalkylaminoalkyl-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2571374A1 (fr) Nouveaux derives de 5-fluoro-2'-desoxyuridine et leurs sels, leur procede de preparation, et agents antitumoraux les contenant
EP0433267B1 (fr) Préparation de l'acide éicosatétraynoique
FR2595703A1 (fr) Nouveaux phospholipides, leur procede et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
EP0229128A1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen präparate.
EP0043472A1 (en) 3-Hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same
US4160773A (en) Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use
EP0579939A1 (de) Neue Phospholipidderivate
US4565659A (en) Substituted aminoalkanol phospholipids
JP4210744B2 (ja) スフィンゴ脂質誘導体
EP0574312A1 (fr) Nicotinates de diacylglycérols, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0403318A1 (fr) Procédé de préparation d'une nouvelle substance antitumorale, l'amino-3 (amino-2 1H-imidazolyl-4-)-1 chloro-2 propanol-1 et de ses sels sous forme racémique thréo, utilisable comme médicament
FR2585706A1 (fr) Esters du type 2-hydroxy 3-halogenopropylphosphates et leur procede de preparation

Legal Events

Date Code Title Description
YP Annual fee paid